Cookies on this website

We use cookies to ensure that we give you the best experience on our website. If you click 'Continue' we'll assume that you are happy to receive all cookies and you won't see this message again. Click 'Find out more' for information on how to change your cookie settings.

Could multi-cancer blood tests help GPs identify cancer sooner? Our Cancer Theme travelled to Carlisle to hear local perspectives on cancer diagnosis, access to research and the ARMADILO study, exploring how new tests could work for rural and underserved communities.

Associate Professor Brian Nicholson and Dr Tanvi Rai leading consultation in Carlisle
Associate Professor Brian Nicholson – and Dr Tanvi Rai leading consultation

One in two patients who are later diagnosed with cancer initially visit their NHS GP with ‘non-specific’ symptoms such as stomach pain or weight loss. These symptoms are common and can have many causes both serious and benign. This creates a difficult challenge for GPs to identify which patients need further investigation without referring everyone with these symptoms to hospital.

For patients with these symptoms which turn out not to be a sign of cancer, this uncertainty can mean repeated visits to their GP, delayed referral, later stage diagnosis and subsequently poorer prognosis. 

But what if GPs had another tool to help them decide who should be referred for further investigations for cancer?

Multi-cancer tests (MCTs) could offer one such approach. These tests use a blood sample as a  type of ‘liquid biopsy’ that detect signals of the presence of cancer across a range of cancer sites. If shown to be effective in primary care, MCTs could help GPs with decision making on which patients to refer for further cancer testing while providing reassurance for others.

Understanding how these tests might work in everyday primary care is therefore crucial, not only from a clinical perspective but from the experience of the patients and communities who may be asked to take them.

In the Cancer Theme, we work with diverse communities across England to raise awareness of our research and, importantly, to give people – often those from groups that have traditionally been underserved by research -  a direct route to sharing their views to help shape it. The team behind this community engagement work were awarded ‘Highly Commended’ in the Creative category at the 2026 Department Value Awards in recognition of this work.

Our outreach programme helps us to reach diverse  communities facing high levels of socio-economic deprivation, cancer inequalities, geographical and rural deprivation and inequitable access to clinical research. These conversations allow us to hear directly from local people about how MCTs might be introduced into primary care and what researchers need to consider when designing studies involving these tests.

One such study is ARMADILO, the first evaluation of MCT’s in primary care. ARMADILO is an observational study involving patients aged 50 and over, who have visited their GP with at least one non- specific symptom that could indicate cancer, such as weight loss.  Participants are invited to provide an additional blood sample for multi-cancer testing.

Cumbria is one of the areas taking part. To understand how research might be received locally and to hear directly about the challenges facing people accessing healthcare and research in rural communities, we travelled to Carlisle for a community consultation event.

What we heard went well beyond views about MCTs. Participants spoke about accessing GPs, the difficulties of taking part in research from rural Cumbria, the importance of advocating for yourself when something does not feel right, and how existing community health services could help make future cancer research more accessible. 

Highlights of the Community Consultation Event

We first got in touch with People First, an advocacy charity that the Health Watch service in Cumbria. We held regular online meetings with the Healthwatch Cumberland team and planned the event for Carlisle as it was a familiar location to people from the wider area.

We partnered with the following local organisations to host our event:

Healthwatch Cumbria- work with a range of groups including trans community, youth mental health, addiction, and resilience to improve services for patients.

Eden Primary Care Network – A network of 10 GP practices, offering a range of services, including cancer patient coordinators who searches through the primary care records for newly diagnosed cancer patients and support them by referring or signposting them.

Cumbria Health - A primary care services health provider that provides both out of hours and non out of hours services. Supports people with long term health conditions and cancer survivors to get back to work, and works with employers to consider things like reasonable adjustments. At the event they provided diabetic testing and Q risk score calculations to support people with their health through outreach events.

PCN Cancer Engagement Lead for North Cumbria (Northern Cancer Alliance) – Outlined the work undertaken on targeted innovation to increase Lung Cancer Health Check (lung cancer screening) by removing barriers.

Eden Partners talking about their services Eden Partners talking about their services

Participant Experience and knowledge on Research

During the event, participants were asked about their knowledge and experience of clinical trials, of which there were different experiences:

One patient commented that research happened in secondary care and they and their family had asked the team on the ward what research was ongoing. They felt that research was a way to have “a second tier of monitoring” and they got better attention and care through the research team than the NHS team.

Other participants reported that not enough clinicians were research active and aware of ongoing projects - “I had to do the work”. When they looked for NHS research projects, they all involved travelling to Newcastle and there was concern about the lack of research available for rural communities in Cumbria itself. Similarly, others described accessing NHS Cumbria website, but there were not many trials taking place in Cumbria

Associate Professor Brian Nicholson – and Dr Tanvi Rai leading consultation Associate Professor Brian Nicholson – and Dr Tanvi Rai leading consultation

Scenarios

Next, participants discussed two patient scenarios involving people experiencing non-specific symptoms that could indicate cancer. Working in small groups, they explored how each patient might seek healthcare and the challenges they could encounter along the way.

These discussions highlighted differences in access to primary care across Cumbria. Participants felt that although access to a GP was difficult in the main towns it was often better in rural practices.

Participants also raised concerns about communication with primary care professionals. Limited opportunities to speak directly with a GP sometimes left people feeling that their concerns were not fully heard or understood. The group also questioned how effectively digital systems, such as e-Consult, allow patients to describe non-specific symptoms that may be difficult to discuss through a standard online form.

The scenarios also highlighted the importance of self–advocacy. Participants felt that awareness of potential cancer symptoms could vary between health professionals and that patients sometimes needed to be persistent when seeking further investigation. For some, this meant it was crucial for them to push to be referred for further testing.

There was an overall consensus among participants that “We should not be trying to set up new things, we have enough services, and they could help”. The example was given of district nurses as professionals who interacted with local people in their localities or homes and could be involved in giving information out. Such services were crucial as some communities and people in some occupations did not go to their GP.

Responses to ARMADILO Study

When discussing the ARMADILO study, participants were asked for their thoughts on how information about the blood sample required for the AMRADILO study should be communicated, including how the volume of blood should be described and how the sample would be collected.

Some participants raised concerns about the clinical safety of taking what they perceived to be a significant volume of blood, particularly for people who also donate blood for transfusion. They felt that participant information should clearly explain how much blood would be required, provide reassurance about the safety of the amount taken, give details on how the blood sample would be taken and if this would be a single blood withdrawal.

Confidentiality and anonymity were also important considerations and participants wanted reassurance that personal information would be protected. However, they did not express concerns about blood samples being sent to another country for analysis, as long as samples could not be linked to personal identifying information.

The event was very positive as participants felt comfortable sharing their stories and experiences and understood the need for MCTs. As Chloe Wallace, Community Engagement Manager, Healthwatch Cumberland, reinforced:

“I felt that this event was a really safe space to ask questions, to delve further in to how clinical trials work and to learn about what some of the barriers may be to public and patients who may not usually get a chance to have these kind of open discussions.

“There were opportunities for people to share their experiences and be vulnerable, for relationships and new connections to be made. It is somewhere between the triangle of education, expertise, and experience where magic happens. Where we can learn and ultimately make positive changes for a better future for all”.

Future Work

In the Cancer Theme, we aim to plan another event with Healthwatch Cumberland, where we will present the ARMADILO study to additional groups that have low participation rates in research, such as people with disabilities, asylum seekers and refugees and people facing homelessness to explore any variations in responses.

We have also been inspired by one participant Ian, who is living with a stage 4 bowel cancer diagnosis and would like to improve services for other cancer patients in Cumbria by raising funds to establish a Maggie’s Centre in the region. The lack of a Maggie’s Centre demonstrates some of the challenges faced by rural communities in securing equitable health care. Ian is fundraising by walking the Lake District Wainrights.

You can hear directly from Ian on our community engagement page and support his fundraising at Ian Teasdale is fundraising for Maggie's Centres

We would like to thank all who came along on the day to meet us and especially would like to thank our community partners:

Healthwatch Cumberland, Westmorland & Furness and Lancashire

Eden Primary Network

Cumbria Health

Northern Cancer Alliance

Special thanks to Ian.

You can learn more about our community engagement work at https://www.phc.ox.ac.uk/research/research-themes/cancer/projects/community-engagement

Opinions expressed are those of the author/s and not of the University of Oxford. Readers' comments will be moderated - see our guidelines for further information.